Brii Biosciences Company Top Insiders
BRIBF Stock | USD 0.13 0.00 0.00% |
Brii Biosciences employs about 123 people. The company is managed by 10 executives with a total tenure of roughly 287 years, averaging almost 28.0 years of service per executive, having 12.3 employees per reported executive. Examination of Brii Biosciences' management performance can provide insight into the company performance.
Lianhong Xu Insider Head Discovery |
Zhi Hong Insider Ex Cofounder |
Brii |
Brii Biosciences Management Team Effectiveness
The company has return on total asset (ROA) of (0.1877) % which means that it has lost $0.1877 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (5.3439) %, meaning that it generated substantial loss on money invested by shareholders. Brii Biosciences' management efficiency ratios could be used to measure how well Brii Biosciences manages its routine affairs as well as how well it operates its assets and liabilities.Brii Biosciences Workforce Comparison
Brii Biosciences Limited is number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 6,794. Brii Biosciences claims roughly 123 in number of employees contributing just under 2% to stocks in Biotechnology industry.
Brii Biosciences Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Brii Biosciences Price Series Summation is a cross summation of Brii Biosciences price series and its benchmark/peer.
Brii Biosciences Notable Stakeholders
A Brii Biosciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Brii Biosciences often face trade-offs trying to please all of them. Brii Biosciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Brii Biosciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Lianhong Xu | Head Discovery | Profile | |
Zhi Hong | Ex Cofounder | Profile | |
CFA JD | Company Officer | Profile | |
Karen Neuendorff | Chief HR | Profile | |
Li MD | Chief Officer | Profile | |
Qing Zhu | Head RD | Profile | |
Coy Stout | Head Advocacy | Profile | |
Eleanor Groot | Chief Officer | Profile | |
Susannah Cantrell | Chief Officer | Profile | |
MPH MD | VP Area | Profile |
About Brii Biosciences Management Performance
The success or failure of an entity such as Brii Biosciences often depends on how effective the management is. Brii Biosciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Brii management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Brii management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Brii Biosciences Limited engages in the development of medicines for the treatment of infectious and central nervous system diseases. The company was incorporated in 2017 and is based in Beijing, China. Brii Bioscience is traded on OTC Exchange in the United States.
Brii Biosciences Workforce Analysis
Traditionally, organizations such as Brii Biosciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Brii Biosciences within its industry.Brii Biosciences Manpower Efficiency
Return on Brii Biosciences Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 33.9M | |
Net Loss Per Executive | 416.4M |
Complementary Tools for Brii Pink Sheet analysis
When running Brii Biosciences' price analysis, check to measure Brii Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brii Biosciences is operating at the current time. Most of Brii Biosciences' value examination focuses on studying past and present price action to predict the probability of Brii Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brii Biosciences' price. Additionally, you may evaluate how the addition of Brii Biosciences to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |